BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

568 related articles for article (PubMed ID: 31375576)

  • 1. Immunization of BLT Humanized Mice Redirects T Cell Responses to Gag and Reduces Acute HIV-1 Viremia.
    Claiborne DT; Dudek TE; Maldini CR; Power KA; Ghebremichael M; Seung E; Mellors EF; Vrbanac VD; Krupp K; Bisesi A; Tager AM; Knipe DM; Boutwell CL; Allen TM
    J Virol; 2019 Oct; 93(20):. PubMed ID: 31375576
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Novel Immunogen Selectively Eliciting CD8
    Ishii H; Terahara K; Nomura T; Takeda A; Okazaki M; Yamamoto H; Tokusumi T; Shu T; Matano T
    J Virol; 2020 Mar; 94(8):. PubMed ID: 32024773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of human immunodeficiency virus (HIV)-specific T-cell immunity in control of dual HIV-1 and HIV-2 infection.
    Zheng NN; McElrath MJ; Sow PS; Hawes SE; Diallo-Agne H; Stern JE; Li F; Mesher AL; Robinson AD; Gottlieb GS; Huang Y; Kiviat NB
    J Virol; 2007 Sep; 81(17):9061-71. PubMed ID: 17582003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Broad and persistent Gag-specific CD8+ T-cell responses are associated with viral control but rarely drive viral escape during primary HIV-1 infection.
    Radebe M; Gounder K; Mokgoro M; Ndhlovu ZM; Mncube Z; Mkhize L; van der Stok M; Jaggernath M; Walker BD; Ndung'u T
    AIDS; 2015 Jan; 29(1):23-33. PubMed ID: 25387316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD8
    Murakoshi H; Zou C; Kuse N; Akahoshi T; Chikata T; Gatanaga H; Oka S; Hanke T; Takiguchi M
    Retrovirology; 2018 Jul; 15(1):46. PubMed ID: 29970102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Innate Immune Reconstitution in Humanized Bone Marrow-Liver-Thymus (HuBLT) Mice Governs Adaptive Cellular Immune Function and Responses to HIV-1 Infection.
    Garcia-Beltran WF; Claiborne DT; Maldini CR; Phelps M; Vrbanac V; Karpel ME; Krupp KL; Power KA; Boutwell CL; Balazs AB; Tager AM; Altfeld M; Allen TM
    Front Immunol; 2021; 12():667393. PubMed ID: 34122425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Control of HIV-1 Pathogenesis in Viremic Nonprogressors Is Independent of Gag-Specific Cytotoxic T Lymphocyte Responses.
    Salgado M; Garcia-Minambres A; Dalmau J; Jiménez-Moyano E; Viciana P; Alejos B; Clotet B; Prado JG; Martinez-Picado J
    J Virol; 2018 Jun; 92(12):. PubMed ID: 29593044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapid evolution of HIV-1 to functional CD8⁺ T cell responses in humanized BLT mice.
    Dudek TE; No DC; Seung E; Vrbanac VD; Fadda L; Bhoumik P; Boutwell CL; Power KA; Gladden AD; Battis L; Mellors EF; Tivey TR; Gao X; Altfeld M; Luster AD; Tager AM; Allen TM
    Sci Transl Med; 2012 Jul; 4(143):143ra98. PubMed ID: 22814851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deficiency of HIV-Gag-specific T cells in early childhood correlates with poor viral containment.
    Huang S; Dunkley-Thompson J; Tang Y; Macklin EA; Steel-Duncan J; Singh-Minott I; Ryland EG; Smikle M; Walker BD; Christie CD; Feeney ME
    J Immunol; 2008 Dec; 181(11):8103-11. PubMed ID: 19018003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of robust cellular and humoral virus-specific adaptive immune responses in human immunodeficiency virus-infected humanized BLT mice.
    Brainard DM; Seung E; Frahm N; Cariappa A; Bailey CC; Hart WK; Shin HS; Brooks SF; Knight HL; Eichbaum Q; Yang YG; Sykes M; Walker BD; Freeman GJ; Pillai S; Westmoreland SV; Brander C; Luster AD; Tager AM
    J Virol; 2009 Jul; 83(14):7305-21. PubMed ID: 19420076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Poor lymphoproliferative responses with low proportion of Gag-specific CD8 TEMRA cells in HIV-1-infected patients showing immunological and virological discordance despite prolonged suppression of plasma viremia.
    Sachdeva N; Weinstein JE; Ashman M; Sachdeva M; Brewer TH; Gracia D; Asthana D
    Viral Immunol; 2010 Feb; 23(1):49-61. PubMed ID: 20121402
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Virus-like vaccines against HIV/SIV synergize with a subdominant antigen T cell vaccine.
    Schwerdtfeger M; Andersson AC; Neukirch L; Holst PJ
    J Transl Med; 2019 May; 17(1):175. PubMed ID: 31126293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two Distinct Mechanisms Leading to Loss of Virological Control in the Rare Group of Antiretroviral Therapy-Naive, Transiently Aviremic Children Living with HIV.
    Vieira VA; Adland E; Grayson NE; Csala A; Richards F; Dacon C; Athavale R; Tsai MH; D'Souza R; Muenchhoff M; Bonsall D; Jooste P; Goulder PJR
    J Virol; 2022 Jan; 96(2):e0153521. PubMed ID: 34757843
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced anti-HIV functional activity associated with Gag-specific CD8 T-cell responses.
    Julg B; Williams KL; Reddy S; Bishop K; Qi Y; Carrington M; Goulder PJ; Ndung'u T; Walker BD
    J Virol; 2010 Jun; 84(11):5540-9. PubMed ID: 20335261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined Env- and Gag-specific T cell responses in relation to programmed death-1 receptor and CD4 T cell loss rates in human immunodeficiency virus-1 infection.
    Pettersen FO; Taskén K; Kvale D
    Clin Exp Immunol; 2010 Aug; 161(2):315-23. PubMed ID: 20491784
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA Priming Increases Frequency of T-Cell Responses to a Vesicular Stomatitis Virus HIV Vaccine with Specific Enhancement of CD8
    Li SS; Kochar NK; Elizaga M; Hay CM; Wilson GJ; Cohen KW; De Rosa SC; Xu R; Ota-Setlik A; Morris D; Finak G; Allen M; Tieu HV; Frank I; Sobieszczyk ME; Hannaman D; Gottardo R; Gilbert PB; Tomaras GD; Corey L; Clarke DK; Egan MA; Eldridge JH; McElrath MJ; Frahm N;
    Clin Vaccine Immunol; 2017 Nov; 24(11):. PubMed ID: 28931520
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pol-Driven Replicative Capacity Impacts Disease Progression in HIV-1 Subtype C Infection.
    Ojwach DBA; MacMillan D; Reddy T; Novitsky V; Brumme ZL; Brockman MA; Ndung'u T; Mann JK
    J Virol; 2018 Oct; 92(19):. PubMed ID: 29997209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. mRNA-based dendritic cell vaccination induces potent antiviral T-cell responses in HIV-1-infected patients.
    Van Gulck E; Vlieghe E; Vekemans M; Van Tendeloo VF; Van De Velde A; Smits E; Anguille S; Cools N; Goossens H; Mertens L; De Haes W; Wong J; Florence E; Vanham G; Berneman ZN
    AIDS; 2012 Feb; 26(4):F1-12. PubMed ID: 22156965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaccine-induced gag-specific T cells are associated with reduced viremia after HIV-1 infection.
    Janes H; Friedrich DP; Krambrink A; Smith RJ; Kallas EG; Horton H; Casimiro DR; Carrington M; Geraghty DE; Gilbert PB; McElrath MJ; Frahm N
    J Infect Dis; 2013 Oct; 208(8):1231-9. PubMed ID: 23878319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single-cell level response of HIV-specific and cytomegalovirus-specific CD4 T cells correlate with viral control in chronic HIV-1 subtype A infection.
    Eller MA; Eller LA; Ratto-Kim S; Ouma BJ; Lo V; de Souza M; Guwatudde D; Nails B; Michael NL; Wabwire-Mangen F; Robb ML; Marovich MA; Sandberg JK; Currier JR
    J Acquir Immune Defic Syndr; 2012 Sep; 61(1):9-18. PubMed ID: 22580564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.